However, we believe that the present findings could be a starting point to stimulate discussion and research on these aspects, which may lead to the discovery of new pathogenic mechanisms in SSc, and elucidate a role for anti-CXCL4/CXCL4-L1 antibodies as disease biomarkers. This evidence concerns the gene PF4 and systemic sclerosis.